Role of ofatumumab in treatment of chronic lymphocytic leukemia

por Veliz, Marays, Pinilla-Ibarz, Javier
Publicado 2011

The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?

por Gamal, Wael, Sahakian, Eva, Pinilla-Ibarz, Javier
Publicado 2022

Biomarkers for determining the prognosis in chronic myelogenous leukemia

por Sweet, Kendra, Zhang, Ling, Pinilla-Ibarz, Javier
Publicado 2013

Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations

por Sweet, Kendra, Pinilla-Ibarz, Javier, Zhang, Ling
Publicado 2014

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib

por Emole, Josephine, Talabi, Taiwo, Pinilla-Ibarz, Javier
Publicado 2016

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

por Chavez, Julio C, Sahakian, Eva, Pinilla-Ibarz, Javier
Publicado 2013

A case report and case review: Chronic myeloid leukemia (CML) blast phase with myelomastocytic differentiation

por Song, Jinming, Liu, Kenian, Pinilla-Ibarz, Javier, Zhang, Hailing
Publicado 2020

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies

por Maharaj, Kamira, Uriepero, Angimar, Sahakian, Eva, Pinilla-Ibarz, Javier
Publicado 2022

Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies

por McDaniel, Jessica M., Pinilla-Ibarz, Javier, Epling-Burnette, P. K.
Publicado 2012

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned

por Pinilla-Ibarz, Javier, Sweet, Kendra L, Corrales-Yepez, Gabriela M, Komrokji, Rami S
Publicado 2016

T315I-mutated myeloid sarcoma

por Zhang, Yumeng, Swoboda, David M., Grover, Aditya, Nodzon, Lisa, Zhang, Ling, Pinilla-Ibarz, Javier
Publicado 2019

Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study

por Kim, Dong-Wook, Saussele, Susanne, Williams, Loretta A., Mohamed, Hesham, Rong, Yuanxin, Zyczynski, Teresa, Pinilla-Ibarz, Javier, Abruzzese, Elisabetta
Publicado 2018

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

por Maharaj, Kamira, Powers, John J., Mediavilla-Varela, Melanie, Achille, Alex, Gamal, Wael, Quayle, Steven, Jones, Simon S., Sahakian, Eva, Pinilla-Ibarz, Javier
Publicado 2020

Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis

por Aulakh, Sonikpreet, Reljic, Tea, Yassine, Farah, Ayala, Ernesto, Chavez, Julio C., Chanan-Khan, Asher, Pinilla-Ibarz, Javier, Kumar, Ambuj, Kharfan-Dabaja, Mohamed A.
Publicado 2020

Electrocardiographic Changes Associated With Ibrutinib Exposure

por Fradley, Michael G., Welter-Frost, Allan, Gliksman, Matthew, Emole, Josephine, Viganego, Federico, Lee, Dae Hyun, Shah, Bijal, Chavez, Julio C., Pinilla-Ibarz, Javier, Schabath, Matthew B.
Publicado 2020

Melanoma and CLL co-occurrence and survival: role of KC history

por Zhao, Yayi, Amorrortu, Rossybelle P., Stewart, Sandra C., Ghia, Kavita M., Williams, Vonetta L., Sondak, Vernon K., Tsai, Kenneth Y., Pinilla-Ibarz, Javier, Chavez, Julio C., Rollison, Dana E.
Publicado 2023

STING regulates BCR signaling in normal and malignant B cells

por Tang, Chih-Hang Anthony, Lee, Avery C., Chang, Shiun, Xu, Qin, Shao, Andong, Lo, Yun, Spalek, Walker T., Pinilla-Ibarz, Javier A., Del Valle, Juan R., Hu, Chih-Chi Andrew
Publicado 2020

PB1945: PATIENT PERSPECTIVES ON CLL TREATMENT SIDE EFFECTS: A SUB-ANALYSIS OF THE VOICE SURVEY

por Tam, Constantine, Pinilla-Ibarz, Javier, Karakus, Volkan, Pavlovsky, Miguel, Stilgebauer, Stephan, Šimkovič, Martin, Fenili, Ana Cristina, Miroli, Miguel Augusto, Castillo, Carolina Garcia, Huntley, Kathryn, Moura, Catherine, Piotrowski, Fernando, Mattar, Mervat
Publicado 2023

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

por Tam, Constantine, Pinilla-Ibarz, Javier, Castillo, Carolina G., Fenili, Ana Cristina, Huntley, Kathryn, Karakus, Volkan, Mattar, Mervat, Miroli, Miguel A., Moura, Catherine, Pavlovsky, Miguel, Piotrowski, Fernando, Šimkovič, Martin, Stilgenbauer, Stephan
Publicado 2023

Loss of AID exacerbates the malignant progression of CLL

por Lee, Avery C., Pingali, Sai Ravi, Pinilla-Ibarz, Javier A., Atchison, Michael L., Koumenis, Constantinos, Argon, Yair, Thomas-Tikhonenko, Andrei, De Trez, Carl, Hu, Chih-Chi Andrew, Tang, Chih-Hang Anthony
Publicado 2022